CYRAMZA
NDC 0002-7669, ramucirumab, solution, from Eli Lilly and Company.
- Product NDC
- 0002-7669
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- SOLUTION
- Route
- INTRAVENOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA125477
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0002-7669 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- RAMUCIRUMAB10 mg/mL
Pharmacologic classes
VEGFR2 Inhibitors [MoA]; Vascular Endothelial Growth Factor Receptor 2 Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-7669-01 | 00002766901 | 1 VIAL, SINGLE-DOSE in 1 CARTON (0002-7669-01) / 10 mL in 1 VIAL, SINGLE-DOSE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/c6080942-dee6-423e-b688-1272c2ae90d4Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=0002-7669
Use it
Look up 0002-7669 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-7669 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-7669. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.